REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 433 filers reported holding REPLIGEN CORP in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $218,170 | +15.4% | 1,166 | +0.2% | 0.01% | +12.5% |
| Q2 2022 | $189,034 | -66.1% | 1,164 | -60.8% | 0.01% | -57.9% |
| Q1 2022 | $558,439 | -51.3% | 2,969 | -31.4% | 0.02% | -51.3% |
| Q4 2021 | $1,146,492 | +55.8% | 4,329 | +70.0% | 0.04% | +39.3% |
| Q3 2021 | $735,769 | +1380.3% | 2,546 | +922.5% | 0.03% | +1300.0% |
| Q2 2021 | $49,705 | -92.8% | 249 | -93.0% | 0.00% | -93.3% |
| Q1 2021 | $694,433 | -4.9% | 3,572 | -6.3% | 0.03% | -18.9% |
| Q4 2020 | $730,302 | +119.6% | 3,811 | +69.1% | 0.04% | +94.7% |
| Q3 2020 | $332,555 | -19.4% | 2,254 | -32.5% | 0.02% | -29.6% |
| Q2 2020 | $412,734 | +52.0% | 3,339 | +18.7% | 0.03% | +17.4% |
| Q1 2020 | $271,567 | +3524.3% | 2,813 | +3372.8% | 0.02% | +2200.0% |
| Q4 2019 | $7,493 | +20.6% | 81 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $6,212 | – | 81 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |